Business
biOasis Announces Voting Results for 2017 Annual Meeting
biOasis Announces Voting Results for 2017 Annual Meeting.
About this update from Bioasis Technologies Inc.
[{"type":"text","content":"\n \n BIOASIS \n TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) today announced the \n voting results from its Annual General Meeting held on Sept. 21, 2017 in \n Vancouver, British Columbia. The total number of shares represented in \n person or by proxy at the meeting was 17,212,451, representing 33.45% of \n the total issued and outstanding biOasis shares.\n \n \n All directors nominated by management were approved, including new \n members Nancy Stagliano, Ph.D., Deborah Rathjen, Ph.D., and Maha \n Radhakrishnan, M.D. as well as returning members Rob Hutchison \n (Chairman, founder and former chief executive officer), Mark Day, Ph.D. \n (CEO), Ron Erickson and Michael Hutchison, QC. Messrs. Gubitz, Pearson \n and Fibiger were not nominated for re-election to the board at the AGM. \n The Company wishes to thank Messrs. Gubitz, Pearson and Fibiger for all \n of their efforts on behalf of the Company. As previously announced, \n Michael Hutchison will step down from the board in October and Rob \n Hutchison will retire from the company on Dec. 31, 2017.\n \n \n In addition to the new board slate, the shareholders approved the option \n & restricted stock unit (RSU) plans.\n \n \n Election of Directors\n \n \n All seven (7) candidates nominated for election to the biOasis \n Board of Directors and listed in the Company's Management Information \n Circular, dated Aug. 21, 2017, were elected by a majority of the \n shareholders present in person or represented by proxy at the meeting. \n The voting results are as follows:\n \n \n \n \n  \n \n \n  \n \n \n  \n \n \n  \n \n \n  \n \n \n  \n \n \n  \n \n \n  \n \n \n  \n \n \n \n \n NAME\n \n \n  \n \n \n  \n \n \n  \n \n \n VOTES FOR (%)\n \n \n  \n \n \n  \n \n \n  \n \n \n VOTES WITHHELD (%)\n \n \n \n \n Robin Hutchison\n \n \n  \n \n \n  \n \n \n  \n \n \n 15,587,366 (91)\n \n \n  \n \n \n  \n \n \n  \n \n \n 1,620,085 (9)\n \n \n \n \n Mark Day, Ph.D.\n \n \n  \n \n \n  \n \n \n  \n \n \n 17,207,451 (99.9)\n \n \n  \n \n \n  \n \n \n  \n \n \n 0 (0)\n \n \n \n \n Mahalakshmi Radhakrishnan, M.D.\n \n \n  \n \n \n  \n \n \n  \n \n \n 17,146,951 (99.6)\n \n \n  \n \n \n  \n \n \n  \n \n \n 60,500 (<0.01)\n \n \...